Specificity in proteomics

The standard you can’t compromise

False positives don’t just waste time—they can derail entire projects.
In high-multiplex proteomics, specificity isn’t optional. It’s essential.

That’s why Olink’s PEA technology is designed from the ground up to deliver exceptional specificity, so you can trust the signals you see.

Watch this video to see how poor specificity happens and how Olink solves it

Thinking about your future proteomics experiments?

Discover how easy it is to switch to Olink and elevate your proteomics strategy.

Contact us

PEA-animation-Section-2-platform

“The accuracy of Olink has been validated through comparisons with proteomic measurements based on ELISA and mass spectrometry...establishing it as an emerging standard in the field.”

Chia et al., Nature Medicine, 2025

REad the publication

2000-publications-email--banner

Scientific publications

Easily find relevant studies by filtering them or using the free-text search. Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Search all publications

PEA-animation-Section-2-platform

2000-publications-email--banner

Where specificity meets scale

Introducing Olink® Explore HT

Engineered for exceptional specificity, Olink Explore HT combines a stringent 3-step, 15-factor analytical verification process —backed by 3,000+ peer-reviewed publications—with a high-throughput, clinically relevant assay library.

• ~5,400 protein assays, curated for clinical relevance and biological insight

• Dual-antibody PEA technology for unmatched specificity

• Scalable from biomarker discovery to clinical translation—on a single platform

The result? Confident, scalable biomarker discovery from early research to clinical translation.

Want to dive deeper into the platform?

Discover more biology with confidence with Olink® Explore HT

Dowload the white paper

See it action

Curious how researchers are applying Explore HT in the real world?
From oncology and neurology to cardiovascular and metabolic disease, Olink is powering discoveries that shape the future of precision medicine.

Download our latest eBook

Unlocking the Power of Proteomics: From Discovery to Application

Learn more